SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-050389
Filing Date
2018-09-21
Accepted
2018-09-21 16:32:31
Documents
3
Effectiveness Date
2018-09-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS tv503175_defa14a.htm DEFA14A 27056
2 GRAPHIC image_001.jpg GRAPHIC 10093
3 GRAPHIC image_002.jpg GRAPHIC 7107
  Complete submission text file 0001144204-18-050389.txt   52216
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 181081882
SIC: 2834 Pharmaceutical Preparations